Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms, Castration-Resistant × abiraterone × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 8 Prostatic Neoplasms, Castration-Resistant 1 Neoplasms 1 Neoplasm Metastasis 1 Metastatic Castration-Resistant Prostate Cancer 1 Bulbo-Spinal Atrophy, X-Linked 1 Bites and Stings 1

Interventions

Prednisone 5 enzalutamide 4 Docetaxel 4 Abiraterone Acetate 3 olaparib 1 niraparib 1 fludrocortisone acetate 1 darolutamide 1 cabazitaxel 1 abiraterone 1 Rosuvastatin Calcium 1 Pluvicto 1 Pioglitazone 1 Omeprazole 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06863272 2026-03-16

IDeate-Prostate02

Merck Sharp & Dohme LLC

Phase 1/2 Recruiting

Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon ⚡